Michael Engsig

Chief Executive Officer at NYKODE THERAPEUTICS

Net worth: 24 371 $ as of 31/05/2026

54 year

5 connections

Health Technology

Consumer Services

Commercial Services

Profile

Michael Thyrring Engsig currently works at Nykode Therapeutics ASA, as Chief Executive Officer from 2019 and FluoGuide A, as Independent Director from 2023.
Mr. Engsig also formerly worked at Takeda A, as Director-Research & Development and KLIFO A, as EVP-Drug Development Counselling.
Mr. Engsig received his graduate degree from Technical University of Denmark.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NYKODE THERAPEUTICS ASA 0.02%	10/10/2025	71,794 ( 0.02% )	24 371 $	31/05/2026

Michael Engsig active positions

Companies	Position	Start
NYKODE THERAPEUTICS	Chief Executive Officer	01/01/2019
FLUOGUIDE A/S	Director/Board Member	01/01/2023

All active positions of Michael Engsig

Former positions of Michael Engsig

Companies	Position	End
KLIFO A/S KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services	Corporate Officer/Principal	-
Takeda A/S Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies	Chief Tech/Sci/R&D Officer	-

See the detail of Michael Engsig's experience

Training of Michael Engsig

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Engsig's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Technical University of Denmark Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
KLIFO A/S KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services	Commercial Services
Takeda A/S Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies	Finance
Nykode Therapeutics ASA Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer	Health Technology
FluoGuide A/S FluoGuide A/S Pharmaceuticals: MajorHealth Technology Engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent	Health Technology